The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results from a phase III trial of nivolumab (NIVO) combined with ipilimumab (IPI) in treatment-naive patients (pts) with advanced melanoma (MEL) (CheckMate 067).
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Potenza Therapeutics; Vesuvius Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Jounce Therapeutics; MedImmune; Merck; Polaris; Polynoma; ZIOPHARM Oncology
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Vanna Chiarion-Sileni
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche/Genentech
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche/Genentech
 
Rene Gonzalez
Honoraria - Amgen; Bristol-Myers Squibb; Castle Biosciences; GlaxoSmithKline; Roche/Genentech
Consulting or Advisory Role - Piramal Life Science; Roche/Genentech
Research Funding - Bristol-Myers Squibb; Castle Biosciences; Genentech; GlaxoSmithKline; Merck; Roche/Genentech
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Roche/Genentech
Speakers' Bureau - MSD; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Novartis
 
Jean Jacques Grob
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche/Genentech
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Research Funding - Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
C. Lance Cowey
Employment - Texas Oncology
Leadership - McKesson; US Oncology
Stock and Other Ownership Interests - Texas Oncology
Honoraria - Bristol-Myers Squibb; Castle Biosciences; Celgene; Merck; Novartis
Consulting or Advisory Role - Castle Biosciences; Celgene; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Merck
 
Christopher Lao
No Relationships to Disclose
 
Dirk Schadendorf
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche/Genentech
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche/Genentech
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche/Genentech
 
Pier Francesco Ferrucci
Honoraria - Delcath Systems
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Expert Testimony - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
 
Michael Smylie
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Roche/Genentech
Speakers' Bureau - Bristol-Myers Squibb; Roche/Genentech
 
Reinhard Dummer
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
 
Andrew Hill
Employment - Tasman Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
John B. A. G. Haanen
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Pfizer (Inst)
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst)
 
Michele Maio
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche/Genentech
Research Funding - Bristol-Myers Squibb; MedImmune
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche/Genentech
 
Grant A. McArthur
Consulting or Advisory Role - Provectus
Research Funding - Celgene; Novartis; Pfizer; Ventana Medical Systems
Travel, Accommodations, Expenses - Merck; Roche/Genentech
 
Dana Walker
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Joel Jiang
No Relationships to Disclose
 
Christine E. Horak
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
James M. G. Larkin
Research Funding - Novartis (Inst); Pfizer (Inst)
 
F. Stephen Hodi
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche